EP Patent

EP2254558A1 — Orally disintegrating tablets with speckled appearance

Assigned to Alpex Pharma SA · Expires 2010-12-01 · 15y expired

What this patent protects

Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.

USPTO Abstract

Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.

Drugs covered by this patent

phentermine-hydrochloride (PHENTERMINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2254558A1
Jurisdiction: EP
Classification: —
Expires: 2010-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Alpex Pharma SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.